Innate Pharma S.A. (IPHA) Reports 1H EPS of EUR0.02
Tweet
Share
E-mailGet Alerts IPHA Hot Sheet
Join SI Premium – FREE
Innate Pharma S.A. (NASDAQ: IPHA) reported 1H EPS of EUR0.02. Revenue for the quarter came in at EUR40.2 million.
For earnings history and earnings-related data on Innate Pharma S.A. (IPHA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Innate Pharma S.A. (IPHA) PT Raised to $7 at H.C. Wainwright
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
- Reading (RDI) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
